MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Uveal Neoplasms, eye disorder, head and neck cancer, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, skin disorder, skin neoplasm, uveal disorder, uveal melanoma	Recruiting	Phase 1 / Phase 2	2023-12-04		NCT04729543

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dutch Cancer Society	41
Erasmus Medical Center	271
Jan Ivo Stichting grant	1
Ludwig Institute for Cancer Research	4
Stichting Coolsingel Rotterdam grant	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Erasmus Medical Center	Rotterdam	Netherlands	6